Daewoong Co., Ltd. (KRX:003090)

Market Cap	997.73B
Revenue (ttm)	2.03T
Net Income (ttm)	81.85B
Shares Out	40.89M
EPS (ttm)	2,001.51
PE Ratio	12.19
Forward PE	6.63
Dividend	200.00 (0.82%)
Ex-Dividend Date	Dec 27, 2024

Volume	134,208
Average Volume	183,626
Open	24,250
Previous Close	24,250
Day's Range	24,000 - 24,750
52-Week Range	17,420 - 28,850
Beta	1.05
RSI	58.74
Earnings Date	Aug 14, 2025

About Daewoong

Daewoong Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of pharmaceuticals in South Korea. It is also involved in the real estate rental business; provision of lifestyle-related disease prevention research, business management, public affairs, and facility management services; and processing and sale of food products. The company was formerly known as Daewoong Pharmaceutical Co., Ltd. and changed its name to Daewoong Co., Ltd. in 2002. Daewoong Co., Ltd. was founded in 1945 and is headquartered in Seongnam, South...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1945
• Employees: 379
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 003090

Financial Performance

In 2024, Daewoong's revenue was 1.94 trillion, an increase of 6.79% compared to the previous year's 1.81 trillion. Earnings were 57.89 billion, a decrease of -62.08%.